Although these conditions are rare, a proportion of patients with interstitial lung diseases
(ILDs) may develop a progressive-fibrosing phenotype. Progressive fibrosis is associated …

Background Idiopathic pulmonary fibrosis (IPF) is an interstitial lung disease of unknown
origin. A limited number of small studies show an effect of tobacco smoking on risk of IPF …

There are over 200 interstitial lung diseases (ILDs). In addition to patients with idiopathic
pulmonary fibrosis (IPF), a percentage of patients with other ILDs also develop progressive …

Background: Idiopathic pulmonary fibrosis (IPF) is a fatal lung disease of unknown origin,
with a median patient survival time of~ 3 years after diagnosis without anti-fibrotic therapy. It …

Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive, irreversible, and highly fatal
disease. It is characterized by the increased activation of both fibroblast and myofibroblast …

Background: Changes in calcium metabolism are quite common in sarcoidosis:
hypercalciuria is linked to a persistent clinical phenotype and more active disease. No data …

Introduction Therapeutics exist to treat fibrotic lung disease in adults, but these have not
been investigated in children. Defining biomarkers for pediatric fibrotic lung disease in …

Idiopathic pulmonary fibrosis (IPF) is a progressive disease associated with poor quality of
life. Debilitating symptoms and the reality of shortened survival impact patients' physical and …

Propylene glycol (PG) and vegetable glycerin (VG) are the most common solvents used in
electronic cigarette liquids. No long-term inhalation toxicity assessments have been …

Background: The aim of the research presented here was to find a set of parameters
enabling discrimination between three types of fibroblasts, ie, healthy ones and those …